Industry: Pharmaceutical Region: German Transaction price: US$ 1 million Transaction method: equity investment
Project introduction:
A German enterprise, founded in 1998, adopts innovative technology to become a reliable partner in pharmaceutical and biotechnology industries. It provides the pharmaceutical industry with its long-term proprietary technology in the field of API synthesis technology. Enterprises adopt ISO 9001 quality management system and follow GMP standard. Enterprises can provide possible services in the development of new drugs or imitation synthetic drugs, and can also provide compilation services of AS MF (master document of living substances)/DMF (master document of drugs) and CMC (production control of chemical components)/IMPD (research drug files).
Services provided by enterprises:
1. Study on active pharmaceutical ingredients
As a regional trading partner supplying hospital pharmacies, enterprises can provide customers with a series of selected high-quality pharmaceutical raw materials for personal prescriptions. According to the principle of ICH, the technical personnel of enterprises make and record the stability test of raw materials and drugs.
2. API for clinical trials
From pre-clinical trials to approval, and then to commercial production, enterprises are committed to becoming partners in project selection and jointly pushing projects to the market. For many years, the company has been focusing on the synthesis of small molecular compounds, which can provide necessary analysis and documentation services related to drug development and management. With rich experience in synthesis, multifunctional production equipment and high-quality staff, it can meet the requirements of the project.
3. Customized synthesis
According to the special requirements of customers, communicate effectively and directly, and develop customized and market-oriented products in the laboratory. Over the years, the company has been a reliable service partner in the pharmaceutical and biotechnology industries, and has successfully completed more than 250 projects, including more than 20 drugs at different stages of development.
Cooperation mode:
Seeking the partners who need API synthesis technology in China pharmaceutical field.